Saccharomyces Boulardii

Views 3520
Jump to
Abstracts Focused Research Topics
Download the GMI DOC on this Topic

Focus Your Research

Click any topic below to filter + focus research
27 Diseases Researched for Saccharomyces Boulardii
NameACCKFocus
Diarrhea880Locked
Amebiasis220Locked
Childhood Infections220Locked
Clostridium Infections312Locked
Enterobacteriaceae Infections212Locked
Amoebiasis110Locked
Chemotherapy-Induced Toxicity110Locked
Constipation110Locked
Diarrhea: in Children 110Locked
Gastroenteritis110Locked
Helicobacter Pylori Infection210Locked
Infant Infections110Locked
Mucositis110Locked
Pancreatitis: Acute Necrotizing110Locked
Colitis24Locked
Inflammatory Bowel Diseases24Locked
Celiac Disease: Prevention12Locked
Citrobacter Infection12Locked
Colon Cancer12Locked
IgA Nephropathy12Locked
Inflammation12Locked
Intestinal Cancer12Locked
Polio12Locked
Toxocariasis12Locked
Vaccine-induced Toxicity 12Locked
Clostridium Enterocolitis11Locked
Lipopolysaccharide-Induced Toxicity11Locked
9 Pharmacological Actions Researched for Saccharomyces Boulardii
NameACCKFocus
Anti-Bacterial Agents541Locked
Antiproliferative 23Locked
Apoptotic12Locked
Epidermal growth factor receptor (EGFR) inhibitor12Locked
NF-kappaB Inhibitor12Locked
Tumor Necrosis Factor (TNF) Alpha Inhibitor12Locked
Anti-Inflammatory Agents11Locked
Interleukin-10 upregulation11Locked
Interleukin-6 Downregulation11Locked
Related Topics

Saccharomyces Boulardii is a Sub of the following Topic

View the Evidence:
36 Abstracts with Saccharomyces Boulardii Research

[+]

Addition of S. boulardii to sequential therapy improved H. pylori eradication rate and reduced the incidence of treatment-associated adverse events.Apr 30, 2019

Pubmed Data : Eur J Clin Pharmacol. 2019 May ;75(5):639-645. Epub 2019 Jan 29. PMID: 30694338
Article Published Date : Apr 30, 2019
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Helicobacter Pylori Infection
Pharmacological Actions : Anti-Bacterial Agents
[+]

Clinical efficacy comparison of saccharomyces boulardii and lactic acid as probiotics in acute pediatric diarrhea.Dec 31, 2017

Pubmed Data : J Coll Physicians Surg Pak. 2018 03 ;28(3):214-217. PMID: 29544579
Article Published Date : Dec 31, 2017
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Diarrhea
Pharmacological Actions : Antidiarrheals
[+]

Saccharomyces boulardii and yogurt fluid has therapeutic value in treating acute non-bloody diarrhea in children: a randomized, controlled, open label study.Mar 01, 2010

Pubmed Data : Am J Trop Med Hyg. 2010 Mar;82(3):488-91. PMID: 20207879
Article Published Date : Mar 01, 2010
Study Type : Human Study
Additional Links
Substances : Fermented Foods and Beverages, Saccharomyces Boulardii, Yoghurt
Diseases : Childhood Infections, Diarrhea
[+]

Saccharomyces boulardii CNCM I-745 modulates the fecal bile acids metabolism during antimicrobial therapy.Dec 31, 2018

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Microbiol. 2019 ;10:336. Epub 2019 Mar 4. PMID: 30881353
Article Published Date : Dec 31, 2018
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Antibiotic Toxicity , Clostridium Infections
Pharmacological Actions : Gastrointestinal Agents
Problem Substances : Antibiotics
[+]

Saccharomyces Boulardii diminishes bacterial infections and offers healthbenefits in the therapy of acute necrotizing pancreatitis.Aug 01, 2007

Pubmed Data : Hum Exp Toxicol. 2007 Aug;26(8):653-61 PMID: 17884953
Article Published Date : Aug 01, 2007
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Pancreatitis: Acute Necrotizing
[+]

Saccharomyces boulardii has significant therapeutic activity in irinotecan-induced (chemotherapy) diarrhea and mucositis.Dec 09, 2008

Pubmed Data : Med Oncol. 2008 Dec 9. PMID: 19067257
Article Published Date : Dec 09, 2008
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Chemotherapy-Induced Toxicity, Diarrhea, Mucositis
Additional Keywords : Drug: Iriniotecan
[+]

Saccharomyces boulardii has therapeutic properties in the treatment of acute diarrhea in children.Feb 01, 2007

Pubmed Data : Aliment Pharmacol Ther. 2007 Feb 1;25(3):257-64. PMID: 17269987
Article Published Date : Feb 01, 2007
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Diarrhea, Gastroenteritis
[+]

Saccharomyces boulardii has therapeutic value in treating Clostridium difficile infection.Dec 01, 2009

Pubmed Data : Can J Gastroenterol. 2009 Dec;23(12):817-21. PMID: 20011734
Article Published Date : Dec 01, 2009
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Clostridium Infections, Constipation, Diarrhea
Pharmacological Actions : Anti-Bacterial Agents
[+]

Saccharomyces boulardii improves antibiotic treatment outcome of acute amebiasis. Aug 01, 2003

Pubmed Data : World J Gastroenterol. 2003 Aug;9(8):1832-3 . PMID: 12918131
Article Published Date : Aug 01, 2003
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Amoebiasis
Additional Keywords : Drug-Plant-Vitamin Synergies
[+]

Saccharomyces boulardii improves the clinical efficacy and reduces the side effects of metronidazole treatment for amebiasis. Jun 01, 2009

Pubmed Data : Am J Trop Med Hyg. 2009 Jun;80(6):953-5. PMID: 19478257
Article Published Date : Jun 01, 2009
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Amebiasis, Diarrhea
Additional Keywords : Drug: Metronidazole, Drug Side Effect Attenuation
[+]

Saccharomyces boulardii inhibits Escherichia colia infection in children. Jun 01, 2006

Pubmed Data : Pediatr Nephrol. 2006 Jun;21(6):807-10. Epub 2006 Apr 20. PMID: 16703374
Article Published Date : Jun 01, 2006
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Childhood Infections, Enterobacteriaceae Infections
Pharmacological Actions : Anti-Bacterial Agents
[+]

Saccharomyces boulardii is an effective adjuvant in treating acute childhood diarrhoea. Apr 01, 2007

Pubmed Data : Acta Paediatr. 2007 Apr;96(4):538-41. Epub 2007 Feb 14. PMID: 17306006
Article Published Date : Apr 01, 2007
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Diarrhea, Diarrhea: in Children , Infant Infections
[+]

Saccharomyces boulardii is an effective and safe treatment for prevention of antibiotic-associated diarrhoea when given concomitantly to patients receiving H. pylori eradication.Jan 01, 2011

Pubmed Data : Wei Sheng Yan Jiu. 2011 Jan;40(1):103-6. PMID: 16292090
Article Published Date : Jan 01, 2011
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Diarrhea, Helicobacter Pylori Infection
Pharmacological Actions : Anti-Bacterial Agents
Additional Keywords : Drug Side Effect Attenuation
[+]

Saccharomyces boulardii is as effective as the drug metronidazole in treating amebiasis-associated diarrhea in children.May 01, 2009

Pubmed Data : Turk J Pediatr. 2009 May-Jun;51(3):220-4. PMID: 19817264
Article Published Date : May 01, 2009
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Amebiasis, Diarrhea
Pharmacological Actions : Anti-Bacterial Agents
Additional Keywords : Drug: Metronidazole, Natural Substances Versus Drugs
[+]

The combination of Saccharomyces boulardi and levocetirine hydrochloride in the treatment of children with allergic rhinitis has obvious clinical efficacy.Nov 04, 2017

Pubmed Data : Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Nov 5 ;31(21):1649-1652. PMID: 29798120
Article Published Date : Nov 04, 2017
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Allergic Rhinitis
Pharmacological Actions : Anti-Allergic Agents, Interferon Inducers, Interleukin-4 downregulation
[+]

The results from this controlled prospective study indicate that S. boulardii is effective for the prevention of clostridium difficile infection.Jul 31, 2018

Pubmed Data : Eur J Clin Microbiol Infect Dis. 2018 Aug ;37(8):1431-1439. Epub 2018 May 3. PMID: 29725956
Article Published Date : Jul 31, 2018
Study Type : Human Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Clostridium Infections
Pharmacological Actions : Anti-Bacterial Agents, Prophylactic Agents
[+]

Reduction in obsessive compulsive disorder and self-injurious behaviour with saccharomyces boulardii in a child with autism.Nov 30, 2018

Pubmed Data : Integr Med (Encinitas). 2018 Dec ;17(6):38-41. PMID: 31043927
Article Published Date : Nov 30, 2018
Study Type : Human: Case Report
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Autism, Obsessive-Compulsive Disorder
Pharmacological Actions : Antidiarrheals, Gastrointestinal Agents, Immunomodulatory
[+]

"Saccharomyces boulardii reduces infection intensity of mice with toxocariasis."Jan 08, 2012

Pubmed Data : Vet Parasitol. 2012 Jan 8. Epub 2012 Jan 8. PMID: 22305116
Article Published Date : Jan 08, 2012
Study Type : Animal Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Toxocariasis
[+]

Gluten induces coeliac-like disease in sensitised mice that is prevented by probiotics.Feb 13, 2012

Pubmed Data : Lab Invest. 2012 Feb 13. Epub 2012 Feb 13. PMID: 22330344
Article Published Date : Feb 13, 2012
Study Type : Animal Study
Additional Links
Substances : Probiotics, Saccharomyces Boulardii
Diseases : Celiac Disease: Prevention
Problem Substances : Gluten
[+]

Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis.Nov 30, 2018

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Mol Med Rep. 2018 Dec ;18(6):5652-5662. Epub 2018 Oct 30. PMID: 30387820
Article Published Date : Nov 30, 2018
Study Type : Animal Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Colitis
Pharmacological Actions : Hypoxia inducible factor-1 alpha (HIF-1α) inhibitor, Vascular Endothelial Growth Factor Inhibitors
[+]

S. boulardii reduces colonic inflammation in a rat experimental model of Colitis.Jul 10, 2008

Pubmed Data : Dig Dis Sci. 2008 Jul 10. PMID: 18612822
Article Published Date : Jul 10, 2008
Study Type : Animal Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Colitis, Inflammatory Bowel Diseases
Pharmacological Actions : Tumor Necrosis Factor (TNF) Alpha Inhibitor
Additional Keywords : Epigenetic Modification
[+]

Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.Jan 01, 2008

Pubmed Data : Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G295-306. Epub 2007 Nov 21. PMID: 18032474
Article Published Date : Jan 01, 2008
Study Type : Animal Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Citrobacter Infection, Colitis, Enterobacteriaceae Infections
[+]

Saccharomyces boulardii CNCM I-745 changes lipidemic profile and gut microbiota in a hypercholesterolemic model.May 27, 2019

Pubmed Data : Benef Microbes. 2019 May 28 ;10(5):555-567. Epub 2019 May 15. PMID: 31090460
Article Published Date : May 27, 2019
Study Type : Animal Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Hypercholesterolemia
Pharmacological Actions : Gastrointestinal Agents, Hypolipidemic
[+]

Saccharomyces boulardii exerted intestinal anti-inflammatory effects in DSS-mouse colitis.Oct 31, 2018

Pubmed Data : J Nutr Biochem. 2018 Nov ;61:129-139. Epub 2018 Sep 1. PMID: 30236870
Article Published Date : Oct 31, 2018
Study Type : Animal Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Colitis
Pharmacological Actions : Anti-Inflammatory Agents
[+]

Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.Dec 01, 2006

Pubmed Data : Gastroenterology. 2006 Dec;131(6):1812-25. PMID: 17087945
Article Published Date : Dec 01, 2006
Study Type : Animal Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Inflammation, Inflammatory Bowel Diseases
Pharmacological Actions : NF-kappaB Inhibitor
[+]

Saccharomyces boulardii may have a preventive role in intestinal and colon cancer. Sep 01, 2009

Pubmed Data : Gastroenterology. 2009 Sep;137(3):914-23. Epub 2009 May 29. PMID: 19482027
Article Published Date : Sep 01, 2009
Study Type : Animal Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Colon Cancer, Intestinal Cancer
Pharmacological Actions : Antiproliferative , Apoptotic, Epidermal growth factor receptor (EGFR) inhibitor
[+]

Saccharomyces boulardii prevents oral-poliovirus vaccine-induced IgA nephropathy in mice. Aug 01, 2008

Pubmed Data : Pediatr Nephrol. 2008 Aug;23(8):1287-91. Epub 2008 Apr 30. PMID: 18446380
Article Published Date : Aug 01, 2008
Study Type : Animal Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : IgA Nephropathy, Polio, Vaccine-induced Toxicity
Additional Keywords : Vaccine Toxicity
[+]

The efficacy of S. boulardii in reducing damages caused by Giardia was demonstrated in this study.Sep 17, 2018

Pubmed Data : Benef Microbes. 2018 Sep 18 ;9(5):789-797. Epub 2018 Aug 31. PMID: 30165752
Article Published Date : Sep 17, 2018
Study Type : Animal Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Giardiasis
Pharmacological Actions : Antiparasitic Agents
[+]

Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption.Dec 31, 2018

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Clin Exp Gastroenterol. 2019 ;12:67-82. Epub 2019 Feb 11. PMID: 30804678
Article Published Date : Dec 31, 2018
Study Type : Review
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Inflammatory Bowel Diseases
Pharmacological Actions : Gastrointestinal Agents, Gastroprotective
[+]

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections.May 13, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : World J Gastroenterol. 2019 May 14 ;25(18):2188-2203. PMID: 31143070
Article Published Date : May 13, 2019
Study Type : In Vitro Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Antibiotic Toxicity , Dysbiosis, Gastrointestinal Diseases, Gastrointestinal Inflammation
Pharmacological Actions : Gastrointestinal Agents
Problem Substances : Antibiotics
[+]

S. boulardii could have a potential role in colon cancer prevention.Apr 30, 2018

Pubmed Data : Nutr Cancer. 2018 May-Jun;70(4):632-642. Epub 2018 Apr 26. PMID: 29697280
Article Published Date : Apr 30, 2018
Study Type : In Vitro Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Colon Cancer
Pharmacological Actions : Anticarcinogenic Agents
[+]

Saccharomyces boulardii CNCM I-745 influences the gut-associated immune system.Dec 31, 2016

Pubmed Data : MMW Fortschr Med. 2017 06 ;159(Suppl 5):1-6. Epub 2017 Jun 22. PMID: 28643294
Article Published Date : Dec 31, 2016
Study Type : Review
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Diarrhea, Diarrhea: Bacterial
Pharmacological Actions : Antidiarrheals
[+]

Saccharomyces boulardii inhibits lipopolysaccharide-induced inflammation.Apr 01, 2009

Pubmed Data : Clin Exp Immunol. 2009 Apr;156(1):78-87. Epub 2009 Jan 21. PMID: 19161443
Article Published Date : Apr 01, 2009
Study Type : In Vitro Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Lipopolysaccharide-Induced Toxicity
Pharmacological Actions : Anti-Inflammatory Agents, Antiproliferative , Interleukin-10 upregulation, Interleukin-6 Downregulation
[+]

Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.Jan 01, 1999

Pubmed Data : Infect Immun. 1999 Jan;67(1):302-7. PMID: 9864230
Article Published Date : Jan 01, 1999
Study Type : In Vitro Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Clostridium Infections
Pharmacological Actions : Anti-Bacterial Agents
[+]

Saccharomyces boulardii protects against Clostridium difficile toxin A-induced enteritis.Aug 25, 2006

Pubmed Data : J Biol Chem. 2006 Aug 25;281(34):24449-54. Epub 2006 Jun 30. PMID: 16816386
Article Published Date : Aug 25, 2006
Study Type : In Vitro Study
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Clostridium Enterocolitis, Clostridium Infections
[+]

S. boulardii enhances eradication treatment for H. pylori and reduces significantly the incidence of side effects.Jan 01, 2009

Pubmed Data : Acta Paediatr. 2009 Jan;98(1):127-31. Epub 2008 Aug 4. PMID: 18681892
Article Published Date : Jan 01, 2009
Additional Links
Substances : Saccharomyces Boulardii
Diseases : Helicobacter Pylori Infection

Copyright: ilexx / 123RF Stock Photo

Saccharomyces Boulardii Related Articles

8 Ways Microbes Can Save Us From Ourselves
Written by Sayer Ji, Founder
Could bacteria and related microbes, widely believed to be a primary cause of disease, explain how we are capable of surviving through the self-created chemical nightmare of industrialized society?

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.
  • Printer-friendly version

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2023 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.